Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related IPXL
The Coming Drug-Patent Cliff Is Pushing This Portfolio Up
5 Biotechs Leerink Analysts Are Watching
Related JCP
Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company Shares Gain Following Announcement Of Positive ALN-PCSsc Study Results
JC Penney Climbs Back Over $9
J.C. Penney makes a run towards double digits (Seeking Alpha)

Impax Laboratories (NASDAQ: IPXL) dipped 21.00% to $15.80 in the pre-market session. Impax Laboratories reported that the FDA completed its re-inspection of its Hayward manufacturing facility. At the conclusion of this inspection, the FDA issued a new Form 483 with 12 observations.

Hospira (NYSE: HSP) shares dropped 4.10% to $28.55 in pre-market trading. Hospira's trailing-twelve-month ROE is 1.48%.

J.C. Penney Co (NYSE: JCP) shares fell 3.82% to $16.10 in the pre-market trading on reports that a stakeholder is selling a large block of shares in the retailer.

Weyerhaeuser Co (NYSE: WY) dipped 3.17% to $29.00 in the pre-market session. Weyerhaeuser's PEG ratio is 5.65.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (IPXL + HSP)

View Comments and Join the Discussion!

Get Benzinga's Newsletters